A Multicenter Open-label Clinical Study on the Prevention of Premature Ovarian Failure After HSCT

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Hematopoietic Stem Cell TransplantationPremature Ovarian Failure
Interventions
DRUG

leuprorelin

From the initial chemotherapy after diagnosis, patients received a subcutaneous injection of leprorelin in each cycle of chemotherapy including the conditioning treatment prior to transplantation.

DRUG

normal saline

From the initial chemotherapy after diagnosis, patients received a subcutaneous injection of normal saline in each cycle of chemotherapy including the conditioning treatment prior to transplantation.

Trial Locations (1)

710061

First Affiliated Hospital of Xian Jiaotong University, Xi'an

All Listed Sponsors
lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER

NCT05667428 - A Multicenter Open-label Clinical Study on the Prevention of Premature Ovarian Failure After HSCT | Biotech Hunter | Biotech Hunter